State Street Corp Summit Therapeutics Inc. Put Options Transaction History
State Street Corp
- $2.59 Trillion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding SMMT
# of Institutions
259Shares Held
90.4MCall Options Held
4.71MPut Options Held
3.17M-
Baker Bros. Advisors LP New York, NY33.7MShares$620 Million7.27% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.67MShares$160 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$145 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.91MShares$71.8 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA2.93MShares$54 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $3.7B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...